NeoMatrix Therapeutics
NeoMatrix Therapeutics is a clinical-stage company dedicated to developing novel, bioactive peptides aimed at preventing injury progression and enhancing tissue healing, particularly in severe burn cases. Founded by Dr. Richard A. Clark, the company focuses on innovative therapies that significantly improve the quality of life and clinical outcomes for burn patients.
NeoMatrix Therapeutics
25 Health Sciences Drive, Suite 124, Stony Brook, NY 11790
What We Do
A novel, bioactive peptide for intravenous treatment of burns within 2 to 4 hours of injury, designed to limit burn injury progression, shorten healing time, and reduce scarring.
A novel, bioactive peptide for intravenous and topical treatment of burns within 8 to 24 hours post-injury, aimed at limiting burn injury progression and reducing scarring.
Battlefield Resuscitation
Key People
Founder, President & Chief Scientific Officer